Condensed Consolidated Statements of Stockholders' Equity (Deficit) (unaudited) - USD ($)
|
Total |
Preferred Stock |
Common Stock |
Common Shares Issuable |
Additional Paid-in Capital |
Accumulated Deficit |
Non controlling Interest |
Balance, shares at Dec. 31, 2019 |
|
2,449,778
|
4,104,982
|
|
|
|
|
Balance, amount at Dec. 31, 2019 |
$ (19,310,000)
|
$ 3,000
|
$ 4,000
|
$ 0
|
$ 548,184,000
|
$ (567,332,000)
|
$ (169,000)
|
Beneficial conversion feature of convertible notes, shares |
|
|
62,647
|
|
|
|
|
Beneficial conversion feature of convertible notes, amount |
213,000
|
0
|
$ 0
|
0
|
213,000
|
0
|
0
|
Issuance of common stock for settlement of litigation, shares |
|
|
205,882
|
|
|
|
|
Issuance of common stock for settlement of litigation, amount |
29,000
|
0
|
$ 0
|
0
|
29,000
|
0
|
0
|
Common shares issued upon conversion of notes payable, shares |
|
|
63,882
|
|
|
|
|
Common shares issued upon conversion of notes payable, amount |
1,910,000
|
0
|
$ 0
|
0
|
1,910,000
|
0
|
0
|
Fair value of amended convertible notes and warrants |
8,643,000
|
|
|
|
8,643,000
|
|
|
Equity compensation |
146,000
|
0
|
0
|
0
|
146,000
|
0
|
0
|
Net loss |
(19,130,000)
|
$ 0
|
$ 0
|
0
|
|
(19,130,000)
|
0
|
Balance, shares at Jun. 30, 2020 |
|
2,449,778
|
4,437,394
|
|
|
|
|
Balance, amount at Jun. 30, 2020 |
(27,499,000)
|
$ 3,000
|
$ 4,000
|
0
|
559,125,000
|
(586,462,000)
|
(169,000)
|
Balance, shares at Mar. 31, 2020 |
|
2,449,778
|
4,152,908
|
|
|
|
|
Balance, amount at Mar. 31, 2020 |
(20,855,000)
|
$ 3,000
|
$ 4,000
|
0
|
548,347,000
|
(569,040,000)
|
(169,000)
|
Beneficial conversion feature of convertible notes, shares |
|
|
62,647
|
|
|
|
|
Beneficial conversion feature of convertible notes, amount |
213,000
|
0
|
$ 0
|
0
|
213,000
|
0
|
0
|
Issuance of common stock for settlement of litigation, shares |
|
|
205,882
|
|
|
|
|
Issuance of common stock for settlement of litigation, amount |
29,000
|
0
|
$ 0
|
0
|
29,000
|
0
|
0
|
Common shares issued upon conversion of notes payable, shares |
|
|
15,957
|
|
|
|
|
Common shares issued upon conversion of notes payable, amount |
1,747,000
|
0
|
$ 0
|
0
|
1,747,000
|
0
|
0
|
Equity compensation |
146,000
|
0
|
0
|
0
|
146,000
|
0
|
0
|
Net loss |
(17,422,000)
|
$ 0
|
$ 0
|
0
|
|
(17,422,000)
|
0
|
Balance, shares at Jun. 30, 2020 |
|
2,449,778
|
4,437,394
|
|
|
|
|
Balance, amount at Jun. 30, 2020 |
(27,499,000)
|
$ 3,000
|
$ 4,000
|
0
|
559,125,000
|
(586,462,000)
|
(169,000)
|
Balance, shares at Mar. 31, 2020 |
|
2,449,778
|
4,152,908
|
|
|
|
|
Balance, amount at Mar. 31, 2020 |
(20,855,000)
|
$ 3,000
|
$ 4,000
|
0
|
548,347,000
|
(569,040,000)
|
(169,000)
|
Fair value of amended convertible notes and warrants |
8,643,000
|
|
|
|
8,643,000
|
|
|
Balance, shares at Dec. 31, 2020 |
|
2,449,778
|
5,218,122
|
|
|
|
|
Balance, amount at Dec. 31, 2020 |
(29,433,000)
|
$ 3,000
|
$ 5,000
|
0
|
566,356,000
|
(595,628,000)
|
(169,000)
|
Net loss |
(34,538,000)
|
|
|
|
|
(34,538,000)
|
|
Extinguishment of debt discount upon adoption of ASU 2020-06 |
(4,519,000)
|
$ 0
|
$ 0
|
0
|
(4,745,000)
|
226,000
|
0
|
Conversion of Preferred Series J to common stock, shares |
|
(2,353,548)
|
692,220
|
|
|
|
|
Conversion of Preferred Series J to common stock, amount |
0
|
$ (2,000)
|
$ 1,000
|
$ 0
|
1,000
|
0
|
0
|
Common shares issued upon mandatory conversion of notes payable and accrued interest, shares |
|
|
8,261,809
|
3,152,000
|
|
|
|
Common shares issued upon mandatory conversion of notes payable and accrued interest, amount |
38,799,000
|
0
|
$ 8,000
|
$ 10,716,000
|
28,075,000
|
0
|
0
|
Common shares issued upon exercise of warrants, shares |
|
|
3,047,818
|
|
|
|
|
Common shares issued upon exercise of warrants, amount |
16,296,000
|
0
|
$ 3,000
|
0
|
16,293,000
|
0
|
0
|
Issuance of common stock in public offering, net of cost, shares |
|
|
4,945,000
|
|
|
|
|
Issuance of common stock in public offering, net of cost, amount |
24,679,000
|
0
|
$ 5,000
|
0
|
24,674,000
|
0
|
0
|
Issuance of common stock for research and development agreement, shares |
|
|
189,753
|
|
|
|
|
Issuance of common stock for research and development agreement, amount |
$ 1,355,000
|
0
|
$ 0
|
0
|
1,355,000
|
0
|
0
|
Issuance of common stock for services, shares |
189,753
|
|
2,050,060
|
|
|
|
|
Issuance of common stock for services, amount |
$ 8,779,000
|
0
|
$ 2,000
|
0
|
8,777,000
|
0
|
0
|
Equity compensation to officers and board of directors, shares |
|
|
3,739,295
|
|
|
|
|
Equity compensation to officers and board of directors, amount |
14,873,000
|
$ 0
|
$ 4,000
|
$ 0
|
14,869,000
|
0
|
0
|
Balance, shares at Jun. 30, 2021 |
|
96,230
|
28,144,077
|
3,152,000
|
|
|
|
Balance, amount at Jun. 30, 2021 |
36,291,000
|
$ 1,000
|
$ 28,000
|
$ 10,716,000
|
655,655,000
|
(629,940,000)
|
(169,000)
|
Balance, shares at Mar. 31, 2021 |
|
96,230
|
20,517,431
|
7,634,000
|
|
|
|
Balance, amount at Mar. 31, 2021 |
24,017,000
|
$ 1,000
|
$ 21,000
|
$ 25,956,000
|
623,287,000
|
(625,079,000)
|
(169,000)
|
Common shares issued upon conversion of notes payable, shares |
|
|
4,482,487
|
(4,482,000)
|
|
|
|
Common shares issued upon conversion of notes payable, amount |
(4,000)
|
0
|
$ 4,000
|
$ (15,240,000)
|
15,232,000
|
0
|
0
|
Net loss |
(4,861,000)
|
|
|
|
|
(4,861,000)
|
|
Common shares issued upon exercise of warrants, shares |
|
|
2,953,394
|
|
|
|
|
Common shares issued upon exercise of warrants, amount |
16,235,000
|
0
|
$ 3,000
|
0
|
16,232,000
|
0
|
0
|
Issuance of common stock for services, shares |
|
|
92,286
|
|
|
|
|
Issuance of common stock for services, amount |
327,000
|
0
|
$ 0
|
0
|
327,000
|
0
|
0
|
Equity compensation to officers and board of directors, shares |
|
|
98,479
|
|
|
|
|
Equity compensation to officers and board of directors, amount |
577,000
|
$ 0
|
$ 0
|
$ 0
|
577,000
|
0
|
0
|
Balance, shares at Jun. 30, 2021 |
|
96,230
|
28,144,077
|
3,152,000
|
|
|
|
Balance, amount at Jun. 30, 2021 |
$ 36,291,000
|
$ 1,000
|
$ 28,000
|
$ 10,716,000
|
$ 655,655,000
|
$ (629,940,000)
|
$ (169,000)
|